Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

When is it worth measuring a covariate in a randomized clinical trial?

Allison DB.

J Consult Clin Psychol. 1995 Jun;63(3):339-43.

PMID:
7608345
2.
3.

Explaining community-level variance in group randomized trials.

Feng Z, Diehr P, Yasui Y, Evans B, Beresford S, Koepsell TD.

Stat Med. 1999 Mar 15;18(5):539-56.

PMID:
10209810
5.
6.

Covariate adjustment increases statistical power in randomized controlled trials.

Lingsma H, Roozenbeek B, Steyerberg E; IMPACT investigators.

J Clin Epidemiol. 2010 Dec;63(12):1391; author reply 1392-3. doi: 10.1016/j.jclinepi.2010.05.003. No abstract available.

PMID:
20800991
7.

Incorporating cost in power analysis for three-level cluster-randomized designs.

Konstantopoulos S.

Eval Rev. 2009 Aug;33(4):335-57. doi: 10.1177/0193841X09337991. Epub 2009 Jun 9.

PMID:
19509118
8.

Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results.

Elting LS, Shih YC, Stiff PJ, Bensinger W, Cantor SB, Cooksley C, Spielberger R, Emmanoulides C.

Biol Blood Marrow Transplant. 2007 Jul;13(7):806-13. Epub 2007 Apr 23.

9.

How to select covariates to include in the analysis of a clinical trial.

Raab GM, Day S, Sales J.

Control Clin Trials. 2000 Aug;21(4):330-42.

PMID:
10913808
10.

Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods.

Graves N, Walker D, Raine R, Hutchings A, Roberts JA.

Health Econ. 2002 Dec;11(8):735-9. Review.

PMID:
12457373
11.
12.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
13.

Statistical analysis of cost outcomes in a randomized controlled clinical trial.

Rutten-van Mölken MP, van Doorslaer EK, van Vliet RC.

Health Econ. 1994 Sep-Oct;3(5):333-45.

PMID:
7827649
14.

Analytic methods for questions pertaining to a randomized pretest, posttest, follow-up design.

Rausch JR, Maxwell SE, Kelley K.

J Clin Child Adolesc Psychol. 2003 Sep;32(3):467-86.

PMID:
12881035
15.

Economic endpoints in clinical trials.

Hlatky MA.

Epidemiol Rev. 2002;24(1):80-4.

16.

Clinical trial-based cost-effectiveness analyses of antipsychotic use.

Polsky D, Doshi JA, Bauer MS, Glick HA.

Am J Psychiatry. 2006 Dec;163(12):2047-56. Review.

PMID:
17151153
17.

Preliminary data release for randomized clinical trials of noninferiority: a new proposal.

Korn EL, Hunsberger S, Freidlin B, Smith MA, Abrams JS.

J Clin Oncol. 2005 Aug 20;23(24):5831-6. Epub 2005 Jul 18.

18.

ALIFE@Work: a randomised controlled trial of a distance counselling lifestyle programme for weight control among an overweight working population [ISRCTN04265725].

van Wier MF, Ariëns GA, Dekkers JC, Hendriksen IJ, Pronk NP, Smid T, van Mechelen W.

BMC Public Health. 2006 May 24;6:140.

19.

Estimating dose-response effects in psychological treatment trials: the role of instrumental variables.

Maracy M, Dunn G.

Stat Methods Med Res. 2011 Jun;20(3):191-215. doi: 10.1177/0962280208097243. Epub 2008 Nov 26. Review.

PMID:
19036909
20.

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.

Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perucca E, Tomson T.

Epilepsia. 2006 Jul;47(7):1094-120. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk